Brussels, 17/10/2002 (Agence Europe) - The day before the vote at the EP in first reading on the "medicines package" (see yesterday's EUROPE, p.11), and after the environment committee's rejection of the provisions concerning the launching of three pilot projects allowing the industry to directly inform patients on medicines available for the treatment of AIDS, asthma and diabetes, the Merck Sharp & Dohme (MSD) laboratory stressed that the European Parliament should choose next week in...